Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dolei, A.
Right arrow Articles by Sotgiu, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dolei, A.
Right arrow Articles by Sotgiu, S.
Related Collections
Right arrow Viral infections
Right arrow Multiple sclerosis
Neurology 2002;58:471-473
© 2002 American Academy of Neurology


Brief Communications

Multiple sclerosis–associated retrovirus (MSRV) in Sardinian MS patients

A. Dolei, PhD, C. Serra, PhD, G. Mameli, BS, M. Pugliatti, MD, G. Sechi, MD, M. C. Cirotto, BS, G. Rosati, MD and S. Sotgiu, MD

From the Section of Experimental and Clinical Microbiology, Department of Biomedical Sciences (Drs. Dolei and Serra, and G. Mameli), University of Sassari, Viale San Pietro 43/B, I-07100 Sassari; Institute of Clinical Neurology (Drs. Pugliatti, Sechi, Rosati, and Sotgiu), University of Sassari, Viale San Pietro; and Immunohematology Unit (M.C. Cirotto), ASL n. 1 Transfusion Center, Sassari, Italy.

Address correspondence and reprint requests to Prof. A. Dolei, Section of Experimental and Clinical Microbiology, Department of Biomedical Sciences, Viale San Pietro 43/B, I-07100, Sassari, Italy; e-mail: doleivir{at}ssmain.uniss.it

Blood and CSF of Sardinian patients with MS and neurologic control subjects were tested for MS-associated retrovirus (MSRV). CSF detection in MS was 50% at clinical onset, increasing with temporal disease progression, and 40% in control subjects. In blood, MSRV was detected in all MS patients, in most patients with inflammatory neurologic diseases, and rarely in healthy blood donors. MSRV may represent a marker of neurologic diseases of inflammatory origin.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by AAN Enterprises, Inc.